Stem Cell Product CEO Pleads Guilty to Felony Distribution of Unapproved Drug

John Warrington Kosolcharoen admitted to misleading the public and FDA about the safety and efficacy of his company's products, resulting in multiple hospitalizations.

• Kosolcharoen created Liveyon LLC and Genetech Inc. to market stem cell products from umbilical cord blood.
• The products were falsely advertised as treatments for serious conditions like Alzheimer's and heart disease.
• FDA and CDC reports linked these products to bacterial infections in multiple states.
• Kosolcharoen directed false labeling of products as 'for research purposes only' to evade FDA scrutiny.
• Sentencing is scheduled for September 23, with a maximum possible sentence of three years in federal prison.

3 Articles

Orange County Register U.S. Department of Justice U.S. Department of Justice